Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene - PubMed (original) (raw)
Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene
P Busson et al. J Gen Virol. 1995 Jan.
Abstract
Latent membrane protein 2A (LMP-2A) is expressed in Epstein-Barr virus transformed B lymphocytes in vitro and has been detected in various types of EBV-associated malignancies. LMP-2A interferes with membrane signal transduction through phosphorylation of its hydrophilic N-terminal domain and binding of the cellular tyrosine kinases encoded by fyn and lyn. In vitro, the domain can block calcium influx and participate in signal transduction inducing cytokine production. These two activities are differently affected by site-directed mutagenesis of potentially phosphorylated amino acid residues. Several potential tyrosine protein kinase recognition motifs have been identified including an antigen recognition motif (ARAM). ARAMs are activated by tyrosine phosphorylation that enables binding of tyrosine protein kinases such as lyn and fyn. To assess the importance of potential sequence variation in natural EBV infection and in tumourigenesis, the sequence of the LMP-2A N-terminal domain was determined in 28 EBV isolates, including 14 fresh tumour isolates. Comparison of the corresponding sequences with the prototype B95 strain indicates that LMP-2 is generally conserved with a few base pair changes resulting in conservative amino acid changes in an occasional isolate. However, five single-base loci were frequently mutated, resulting in three patterns of sequence polymorphism in exon 1 of LMP-2A. The patterns did not segregate with EBV Type 1 or Type 2 and were detected in both lymphoid and epithelial tissues. Four of the most frequent mutations at loci 166627, 166750, 166796 and 166805 (codons 23, 63, 79 and 82) could potentially affect tyrosine protein kinase binding motifs. The pivotal tyrosines (codons 74 and 85) and leucines (codons 77 and 88) of the LMP-2 ARAM were not affected in any of the isolates, suggesting that ARAM function is important for EBV infection in vivo. However, the inter-spacing positions 79 and 82 were distinct in more than 50% of the isolates. These prevalent polymorphisms could influence interaction of the LMP-2 cytoplasmic domain with specific cellular ligand proteins.
Similar articles
- Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE, Edwards RH, Walling DM, Raab-Traub N. Miller WE, et al. J Gen Virol. 1994 Oct;75 ( Pt 10):2729-40. doi: 10.1099/0022-1317-75-10-2729. J Gen Virol. 1994. PMID: 7931159 - Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates.
Wang X, Liu X, Jia Y, Chao Y, Xing X, Wang Y, Luo B. Wang X, et al. J Gen Virol. 2010 Oct;91(Pt 10):2564-73. doi: 10.1099/vir.0.021881-0. Epub 2010 Jun 16. J Gen Virol. 2010. PMID: 20554797 - Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.
Sample J, Kieff EF, Kieff ED. Sample J, et al. J Gen Virol. 1994 Oct;75 ( Pt 10):2741-6. doi: 10.1099/0022-1317-75-10-2741. J Gen Virol. 1994. PMID: 7931160 - Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review. - Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R. Miller CL, et al. Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Infect Agents Dis. 1994. PMID: 7812651 Review.
Cited by
- 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.
Franken M, Annis B, Ali AN, Wang F. Franken M, et al. J Virol. 1995 Dec;69(12):8011-9. doi: 10.1128/JVI.69.12.8011-8019.1995. J Virol. 1995. PMID: 7494314 Free PMC article. - Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
Lei H, Li T, Li B, Tsai S, Biggar RJ, Nkrumah F, Neequaye J, Gutierrez M, Epelman S, Mbulaiteye SM, Bhatia K, Lo SC. Lei H, et al. Sci Rep. 2015 Nov 23;5:16706. doi: 10.1038/srep16706. Sci Rep. 2015. PMID: 26593963 Free PMC article. - Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.
Fruehling S, Lee SK, Herrold R, Frech B, Laux G, Kremmer E, Grässer FA, Longnecker R. Fruehling S, et al. J Virol. 1996 Sep;70(9):6216-26. doi: 10.1128/JVI.70.9.6216-6226.1996. J Virol. 1996. PMID: 8709248 Free PMC article. - Potential selection of LMP1 variants in nasopharyngeal carcinoma.
Edwards RH, Sitki-Green D, Moore DT, Raab-Traub N. Edwards RH, et al. J Virol. 2004 Jan;78(2):868-81. doi: 10.1128/jvi.78.2.868-881.2004. J Virol. 2004. PMID: 14694118 Free PMC article. - Generating CTLs against the subdominant EBV LMP antigens by transient expression of an A20 inhibitor with EBV LMP proteins in human DCs.
Hong B, Peng G, Berry L, Gottschalk S, Jung JU, Chen SY, Huang XF. Hong B, et al. Gene Ther. 2012 Aug;19(8):818-27. doi: 10.1038/gt.2011.160. Epub 2011 Nov 3. Gene Ther. 2012. PMID: 22052242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous